T1	intervention 39 47	exercise
T2	eligibility 566 605	Overweight, insufficiently active women
T3	intervention-participants 637 639	97
T4	intervention-participants 663 665	98
T5	control 670 683	control group
T6	control-participants 689 691	48
T7	outcome-Measure 921 939	serum sex hormones
T8	outcome-Measure 944 979	sex hormone-binding globulin (SHBG)
T9	outcome-Measure 981 1003	Body fat and lean mass
T10	outcome 1149 1165	Loss of body fat
T11	outcome 1129 1147	target weight loss
T12	outcome 1283 1313	reduction in free testosterone
T13	outcome 1465 1495	difference for androstenedione
T14	outcome 1522 1526	SHBG
T15	outcome 1581 1599	beneficial effects
T16	outcome 1678 1688	oestradiol
T17	outcome 1733 1748	free oestradiol
T18	outcome 1793 1797	SHBG
T19	outcome 1839 1856	free testosterone
